ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

XG005 for Pain Control in Subjects Undergoing Bunionectomy

ClinicalTrials.gov ID: NCT06017999

Public ClinicalTrials.gov record NCT06017999. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 10:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Safety and Efficacy of XG005 Tablets in Subjects Undergoing Bunionectomy

Study identification

NCT ID
NCT06017999
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Xgene Pharmaceutical Group
Industry
Enrollment
450 participants

Conditions and interventions

Conditions

Interventions

  • Placebo tablet Drug
  • XG005 tablet Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 28, 2023
Primary completion
Aug 28, 2024
Completion
Sep 29, 2024
Last update posted
Nov 16, 2025

2023 – 2024

United States locations

U.S. sites
8
U.S. states
5
U.S. cities
8
Facility City State ZIP Site status
Arizona Research Center Phoenix Arizona 85053
Pacific Research Network San Diego California 92128
Clinical Pharmacology of Miami Hialeah Florida 33014
Midwest Clinical Research Center Dayton Ohio 45417
First Surgical Hospital Bellaire Texas 77401
Legent Orthopedic Hospital Carrollton Texas 75006
Memorial Hermann Village Houston Texas 77043
Endeavor Clinical Trials San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06017999, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 16, 2025 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06017999 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →